	US 12,064,401 B2
	Phytonadione compositions and related methods
Phanesh Koneru, Lenoir, NC (US); Sreerarama Murthy Mallipeddi, Lenoir, NC (US); and Jonathan E. Sterling, Lenoir, NC (US)
Assigned to Exela Holdings, Inc., Lenoir, NC (US)
Filed by EXELA HOLDINGS, INC, Lenoir, NC (US)
Filed on Aug. 3, 2021, as Appl. No. 17/392,405.
Application 17/392,405 is a continuation of application No. 16/043,582, filed on Jul. 24, 2018, granted, now 11,077,071, issued on Aug. 3, 2021.
Application 16/043,582 is a continuation of application No. 15/054,797, filed on Feb. 26, 2016, granted, now 10,028,921, issued on Jul. 24, 2018.
Claims priority of provisional application 62/121,869, filed on Feb. 27, 2015.
Prior Publication US 2021/0361593 A1, Nov. 25, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/122 (2006.01); A61J 1/05 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01)

CPC A61K 31/122 (2013.01) [A61J 1/05 (2013.01); A61K 9/0019 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01)]

11 Claims

1. A pharmaceutical composition comprising Phytonadione in its (E) isomer form that has less than or equal to 3% w/w of its (Z) isomer, wherein the composition is free from benzyl alcohol.